Sterling Biotech
Sterling Biotech, headquartered in India, is a prominent player in the pharmaceutical and biotechnology industry, specialising in the production of high-quality pharmaceutical excipients and active pharmaceutical ingredients (APIs). Founded in 1995, the company has established a strong presence in both domestic and international markets, with significant operations across Asia, Europe, and the Americas. Renowned for its innovative approach, Sterling Biotech offers a diverse range of products, including starches, cellulose derivatives, and other excipients that enhance drug formulation. The company’s commitment to quality and sustainability has positioned it as a trusted partner for pharmaceutical manufacturers worldwide. With a focus on research and development, Sterling Biotech continues to achieve notable milestones, reinforcing its reputation as a leader in the biopharmaceutical sector.
DitchCarbon Score
How does Sterling Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sterling Biotech's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sterling Biotech's reported carbon emissions
Sterling Biotech, headquartered in India, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that the company may still be in the early stages of formalising its climate commitments or reporting its emissions data. In the context of the industry, many companies are increasingly focusing on sustainability and setting ambitious targets to reduce their carbon footprints. However, without specific data or commitments from Sterling Biotech, it is challenging to assess their current climate impact or future goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sterling Biotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
